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Abstract Migrant sensory neuropathy (Wartenberg’s
migrant sensory neuritis) is characterized by sudden
numbness in the distribution of one or multiple cutaneous
nerves. To study disease course and outcome, we
prospectively followed 12 patients who presented to our
tertiary referral neuromuscular outpatient clinic between
January 2003 and January 2004. Medical history, neuro-
logical, laboratory and electrophysiological examinations
were obtained from all patients. All patients were reviewed
a second time in 2007, and ﬁve had a follow-up electro-
physiological examination. At the ﬁrst visit, 50% described
an episode of stretching preceding the sensory complaints.
All but three described pain in the affected area before or
concomitant with sensory loss. At clinical examination a
median of six skin areas were affected, and in 75% this
could be conﬁrmed by nerve conduction studies in at least
one nerve. Forty-two percent had involvement of the tri-
geminal nerve. After a mean disease duration of 7.5 years,
three patients reported a complete disappearance of sensory
complaints and ﬁve that the pain had disappeared, but
numbness remained. Three patients still had both painful
and numb sensory deﬁcits. One patient developed a
distal symmetric sensory polyneuropathy. In conclusion,
Wartenberg’s sensory neuritis is a distinct, exclusively
sensory, neuropathy, marked by pain preceding numbness
in affected nerves. An episode of stretching preceding pain
is not necessary for the diagnosis. Wartenberg’s sensory
neuritis often retains its spotty, exclusively sensory char-
acteristics after long term follow-up.
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Introduction
Migrant sensory neuropathy (Wartenberg’s migrant sen-
sory neuritis) is characterized by sudden numbness in the
distribution of one or multiple cutaneous nerves. The
limited number of published clinical studies seems to
suggest that it is a rare disorder. Most studies included few
patients and were retrospective. They generally report a
mild disease course, but follow-up data are scarce [1, 4,
6–8, 11, 13, 14]. In the absence of conclusive diagnostic
tests, Wartenberg’s migrant sensory neuritis remains a
clinical diagnosis. The literature on Wartenberg’s migrant
sensory neuritis suggests that nerves can be affected
sequentially or at the same time [7, 13]. Numbness can be
preceded by painful sensations in the same area. Typically,
stretching of the affected nerve, for example by kneeling
down or abrupt dorsiﬂexion of the foot, sometimes pre-
cedes symptoms [7]. Nerves of the limbs are probably most
commonly affected, but all cutaneous nerves (including
trigeminal or truncal branches) can be affected. Function of
motor nerves is normal [6]. Nerve conduction studies
usually show decreased sensory nerve action potentials
(SNAPs) of the involved nerves [8]. To document the
clinical spectrum and outcome of Wartenberg’s migrant
sensory neuritis we conducted a prospective clinical and
laboratory study with 5 years of follow-up.
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Patients who presented with isolated sensory deﬁcits at our
tertiary referral outpatient clinic for neuromuscular dis-
eases at the University Medical Centre Utrecht (UMCU)
between January 2003 and January 2004 were considered
for inclusion. Exclusion criteria were a generalized
polyneuropathy or a different explanation for the sensory
deﬁcits or painful skin, for example trauma. Patients who
met these criteria and who gave their informed consent
were included in the prospective cohort study.
Medical history, time of onset, disease course, relation to
stretching of nerves, pain, tingling or other sensory disor-
ders, number of affected skin areas (deﬁned as the area of
skin surface with impaired sensation in the cutaneous dis-
tribution of one peripheral nerve), duration of symptoms
were documented. Neurological examination was per-
formed by one of the authors (MvdM) to exclude weakness
or signs compatible with symmetric polyneuropathy, and to
document sensory function of cutaneous nerves.
Erythrocyte sedimentation rate, blood glucose and
angiotensin converting enzyme (ACE) levels, presence of
antinuclear antibodies, extractable nuclear antigen anti-
bodies, and M-protein and anti-Hu antibodies were deter-
mined. Electrophysiological studies included bilateral
recording of sensory nerve action potentials (SNAPs) of the
musculocutaneous, medial cutaneous antebrachii, median,
ulnar, radial, saphenous, superﬁcial peroneal, tibial, lateral
femoral cutaneous and sural nerves. SNAPs were consid-
ered abnormal if the amplitude was below the lower limit
of normal or if the amplitude on the affected side was less
than 50% of the amplitude on the unaffected side [3, 5].
Motor nerve conduction and F-wave studies of the median,
ulnar, tibial and deep peroneal nerves were also performed,
as well as the H reﬂex of the m. soleus.
Between June 2007 and January 2008, we interviewed
all patients by telephone following a standardized ques-
tionnaire. If the interview raised the suspicion of progres-
sion of symptoms or the possibility of another diagnosis,
neurological examination and electrophysiological studies
were repeated.
Results
Twelve patients (six men) out of a total of 750 (1.6%) new
patients presenting to our neuromuscular outpatient clinic
met all inclusion criteria. All but three patients reported
pain either preceding or concomitant with sensory deﬁcits
(Table 1). Six patients (50%) reported pain in the affected
area in the weeks preceding numbness, one described pain
lasting months before numbness set in. The quality of pain
was variously described as stabbing, burning or tingling.
Five (42%) patients reported hyperesthesia in the affected
skin areas. Six (50%) patients reported stretching the
affected skin area or nerve just before pain and numbness
set in. Thus affected were the sural, peroneal, plantar,
saphenal, radial and median nerves, by overextending the
foot for the ﬁrst three, and respectively everting the foot,
ﬂexing the wrist and extending the ﬁngers for the other
nerves. In all patients peripheral nerves of the limbs were
affected, in ﬁve (42%) patients the trigeminal nerve was
also involved and in four (33%) patients areas of the trunk
were affected (Fig. 1). Physical examination yielded deﬁ-
cits in sensory function in a median of six nerves (range 3–
8) per patient. Two patients had neither pain nor persistent
sensory deﬁcits, both reported that they considered their
complaints to be light. One had no abnormalities at elec-
trophysiological examination, the other had lowered and
absent SNAPs of the relevant nerves for his remitting
sensory deﬁcits.
Electrophysiological studies showed abnormal SNAPs of
at least one of the clinically affected nerves in nine (75%)
patients. Electrophysiological conﬁrmation of sensory def-
icits was found in a median of two (range 0–3) nerves per
patient (Table 2). Patient 7 had an asymmetric lowered
SNAP of the peroneal nerve without sensory complaints in
the distribution of the nerve, but all other lowered SNAPs
were of clinically affected nerves. No conduction blocks
were found. Motor nerve conduction studies were normal
except for a lowered CMAP of the m. extensor digitorum
brevis (deep peroneal nerve) of patient 11.
Laboratory abnormalities included non-quantiﬁable IgG
paraproteinemia in two patients and marginally elevated
ACE levels in four patients. All patients were screened for
the presence of anti-Hu, ANA and ENA antibodies, none
tested positive.
Five years after the initial visit to the outpatient clinic
the mean disease duration was 7.5 years (range 5–
14 years). Clinical disease course showed considerable
variation (Table 1). Three patients reported a complete
disappearance of sensory complaints and ﬁve that the pain
had disappeared, but numbness remained. Patient number
5, 6 and 9 still had both painful and numb sensory deﬁcits.
In all patients impact on daily life was limited, although
two patients did describe problems in performing profes-
sional activities. One patient (patient 4 in Tables 1, 2) had
hypoesthesia in a sock and glove pattern with generally
lowered reﬂexes and absent knee and ankle jerks, consis-
tent with distal symmetric sensory polyneuropathy.
In the 5-year follow-up period six out of the remaining
11 patients developed new areas with sensory deﬁcits, in
these patients we regarded disease progression to be
ongoing. Four patients reported a full recovery of sensory
function in the newly affected areas, two developed per-
sistent sensory deﬁcits.
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patients. In patient 1 no abnormalities in SNAP amplitudes
were found, consistent with the disappearance of persistent,
spotty sensory complaints since her inclusion in this study.
An additional abnormally low SNAP of the superﬁcial
peroneal nerve was found in one patient (patient 5),
Table 1 Patient characteristics at study entry and follow-up
Patient Age at
study
entry
Duration of
disease at initial
evaluation
(years)
Sex Presence
of pain
Stretch Number of
affected areas
at study entry
Number of newly
affected areas
during follow-up
Number of
persistent
sensory
deﬁcits
Disease
duration at last
follow-up
(years)
Period of
progressive
disease
(years)
13 41 F ? –7 0 0 5 2
24 42 M ? –5 0 5 7 2
34 52 M – ? 42 07 6
45 33 F ?? 5 Progression to sensory polyneuropathy
55 0 1 0 F ?? 62 7 1 4 [14
64 91 F ?? 53 86 [6
75 85 M ? – 7 0 7 10 4
8 39 6 F – – 5 0 1 10 5
95 41 F ?? 51 55 [5
10 41 1 M ? –5 0 5 7 4
11 42 1 M – – 8 2 0 5 [5
12 57 2 F ?? 31 37 4
Fig. 1 Localization and
frequency of sensory deﬁcits in
all patients at initial visit either
by history taking or
neurological examination.
Colors indicate the number of
times deﬁcits were observed:
green 1, yellow 2, blue 3, purple
4, red 5
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two other patients (patients 7 and 11) there was a decrease
of SNAP amplitudes of the affected nerves that still
showed sensory deﬁcits at follow-up. The patient that had
progressed to polyneuropathy had generally lowered
SNAPs. A cause for the axonal neuropathy could not be
uncovered.
Discussion
After 5-year follow-up all but one patient still had exclu-
sively sensory, spotty complaints. In most patients the
symptoms were remitting and their severity and impact on
daily life were limited, both at initial presentation and after
5 years follow-up. The sensation of stretching preceding
sensory complaints was not very helpful for establishing
the diagnosis as only half of the patients remembered either
physical stretching or a feeling of overstretching preceding
the other symptoms. The presence or absence of stretching
did not lead to a difference in progression or persistence of
sensory complaints. In most patients at least one of the
sensory deﬁcits revealed by history taking or neurological
examination could be conﬁrmed with an abnormal SNAP
of the affected sensory nerve, making small ﬁber neurop-
athy by deﬁnition an unlikely explanation. Only one patient
developed distal symmetrical sensory deﬁcits that eventu-
ally lead to a diagnosis of chronic idiopathic axonal poly-
neuropathy [12]. Whether the spotty sensory complaints at
the initial examination were a rare ﬁrst manifestation of the
polyneuropathy, or if this patient coincidentally developed
two distinct neuropathies, could not be established, because
of the idiopathic nature of both neuropathies. In all other
patients repeated history taking, neurological examination
and ancillary evaluations show no sensory polyneuropathy
or small ﬁber neuropathy (although no techniques were
available to assess function of small sensory nerve ﬁbers)
[2].
The highly variable distribution of affected nerves in
individual patients, and the absence of a progression from
distal to proximal nerves do not point to a length-dependent
etiology. The pattern is more reminiscent of immune-
mediated neuropathies like multifocal motor neuropathy
[9]. In most patients the ﬁrst sensory loss was distally in the
legs or arms. Only two patients had their ﬁrst sensory
abnormalities in the legs, proximally of the knees.
Although we found involvement of the trigeminal nerve
and thoracic nerves in a remarkably high number of
patients, none of them originally presented with sensory
loss in just these areas. The absence of any underlying
cause, the lack of continuous pain and absence of motor
involvement in our patients during follow up also made
mononeuritis multiplex associated with an autoimmune
disease unlikely [10]. For this reason, we refrained from
further investigating the etiology of Wartenberg’s sensory
neuritis by nerve biopsy.
Nerve biopsy studies in Wartenberg patients show
variable and aspeciﬁc changes ranging from perineural
inﬂammatory changes, changes more suggestive of non-
systemic vasculitic neuropathy to axonal degeneration as
seen in ischemic neuronal lesions [1, 6–8, 11, 14]. The
absence of histopathological data in our study precludes
inferring a possible immune-mediated etiology of
Wartenberg’s sensory neuritis. However, our follow-up
Table 2 Sensory deﬁcits found by neurological examination and nerve conduction study at study entry and follow-up
Patient Radial Median Ulnar Peroneal Sural Saphenous Tibial Trigeminal Trunk Lat cut high Digital foot
1 ?? ? * ?? ?* ?
2 ?* ?* ?* ??
3 ?## ?# ?
4 ?? ? * ?* ?
5 ?# ??  ?* ??* ?
6 ?# ?? *# ??
7 ? ?* ?* ?* ?? ?
8 ?? ? ? ?
9 ??*# ?? * ?*
10 ?? * ??* ?
11 ?* ?* ?* ?# ?? ? ?
12 ?# ??
? denotes affected nerves at initial examination
# at follow-up, uni- or bilaterally
* denotes affected nerves with both clinical and electrophysiological (low SNAP amplitude) sensory dysfunction at initial presentation
 at follow-up
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and neurological and electrophysiological ﬁndings consis-
tent with Wartenberg’s sensory neuritis, a nerve biopsy can
reasonably be omitted from the diagnostic work-up. Given
the mild and often remitting course of the disease in our
patient group, the adverse sequelae that may result from
nerve biopsies do seem disproportionate when considering
possible therapeutical beneﬁts and risks of the procedure
for individual patients.
In conclusion, Wartenberg’s sensory neuritis is a clearly
distinct syndrome, leading to relatively mild but persistent
sensory deﬁcits. In this study, laboratory tests in the
absence of positive signs of systemic disease did not yield
any clinically relevant results. Nerve conduction studies
can support the diagnosis. Mainstay for the diagnosis is
exclusion of motor deﬁcits by history taking, neurological
and electrophysiological examination in combination with
the typical complaints of numbness in multiple skin areas
with a sudden onset, after or during painful sensations in
the same area. In these cases, patients can be reassured
about the disease course, as it can be expected to remain
relatively benign, without motor involvement or serious
functional disability.
Open Access This article is distributed under the terms of the
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